google-site-verification: googlec7193c3de77668c9.html

Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

[
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.


Source link

Advertisements
Views: 2

See also  Expert guidance urges caution before surgery for patients with treatment-resistant constipation

Check Also

Costs are top health care issue for midterm voters, but fraud tops GOP list

[ Health care costs top the list of voters’ health care priorities for the midterm …

Stroke center anesthesia practices may shape patient outcomes after mechanical thrombectomy

[ A hospital’s overall experience with general anesthesia (GA) or conscious sedation (CS) may influence …

Novel neurointerventional procedure shows early promise for severe back pain

[ Researchers at the Society of NeuroInterventional Surgery (SNIS) 23rd Annual Meeting presented an experimental …

Leave a Reply

Available for Amazon Prime